Media and Entertainment Media and Entertainment
Tue, January 7, 2025
Mon, January 6, 2025
Sun, January 5, 2025
Sat, January 4, 2025
[ Sat, Jan 04th ] - Yahoo
The 10 best films of 2024
Fri, January 3, 2025
Thu, January 2, 2025
[ Thu, Jan 02nd ] - MSN
15 Best Romantasy Books Of 2024

Meet Karol G, Colombia's Taylor Swift


//media-entertainment.news-articles.net/content/ .. /01/05/meet-karol-g-colombia-s-taylor-swift.html
Published in Media and Entertainment on Sunday, January 5th 2025 at 8:24 GMT by BBC   Print publication without navigation

  • We have all heard of Taylor Swift, but what about Colombian singer Karol G? While Swift has dominated the headlines and concert ticket sales over recent years, it is actually the 33-year-old Latin ...

The article from BBC News discusses the ongoing debate over the use of puberty blockers for transgender youth in the UK. It highlights the recent decision by NHS England to halt the routine prescription of puberty blockers to children and young people, following a review that found insufficient evidence on their safety and effectiveness. This decision has sparked a range of reactions: some see it as a cautious approach to protect children, while others, including transgender advocates and some medical professionals, view it as a setback for transgender healthcare, potentially causing distress to those awaiting treatment. The article also touches on the broader context of transgender healthcare, mentioning the closure of the Tavistock clinic's Gender Identity Development Service and the establishment of new regional hubs to provide more comprehensive care. Additionally, it notes the political and social dimensions of the issue, with references to public opinion, legal challenges, and the need for more research into the long-term effects of these treatments.

Read the Full BBC Article at:
[ https://www.bbc.com/news/articles/ckg3dl757w6o ]

Publication Contributing Sources

Similar Media and Entertainment Publications
[ Wed, Dec 25th 2024 ] - Newsweek
[ Mon, Dec 16th 2024 ] - The Bulwark